Target intelligence / Profile preview

Paracrine cytokine and growth factor network

Molecular classification
Other
01

Overview

The paracrine cytokine and growth factor network is a fundamental system of local intercellular communication where cells secrete signaling molecules to influence the behavior of adjacent cells (Alberts et al., Molecular Biology of the Cell). This network comprises a vast array of proteins, including interleukins, chemokines, and growth factors such as Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor-beta (TGF-beta), which are essential for maintaining tissue homeostasis and coordinating immune responses (Nature Reviews Molecular Cell Biology). In pathological conditions, such as cancer and chronic inflammation, these networks become dysregulated, often creating a microenvironment that supports tumor growth, angiogenesis, and immune evasion (Hanahan & Weinberg, Cell). Therapeutic strategies frequently target specific nodes within this network, utilizing monoclonal antibodies to neutralize ligands or small molecules to inhibit receptor tyrosine kinases (Journal of Clinical Investigation). However, the pleiotropic nature of these signaling molecules means that inhibiting one pathway can lead to significant side effects or the activation of compensatory mechanisms (StatPearls, Cytokines). Consequently, while the network as a whole is a critical driver of disease, drug development focuses on precisely modulating individual components to achieve therapeutic efficacy while minimizing toxicity.

Other names
Paracrine signaling systemIntercellular signaling networkCytokine-growth factor axisLocal cell-to-cell communication network
02

Mechanism of action

Inhibition of specific signaling nodes within the network, including ligand neutralization, receptor antagonism, or kinase inhibition.

03

Biological functions

Signal transductionCell-to-cell communicationImmune responseCell proliferationTissue repairAngiogenesis
04

Disease associations

CancerInflammationAutoimmune diseaseFibrosisCardiovascular disease
05

Safety considerations

Systemic immunosuppressionCytokine release syndromeOff-target effects due to pleiotropyCompensatory pathway activation
06

Interacting drugs

Infliximab

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Serum IL-6 levelsVEGF expression levelsTNF-alpha concentration

Beyond the preview

Go deeper on Paracrine cytokine and growth factor network.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine cytokine and growth factor network.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call